Strong increase in hydroxy fatty acids derived from linoleic acid in human low density lipoproteins of atherosclerotic patients

被引:123
作者
Jira, W
Spiteller, G
Carson, W
Schramm, A
机构
[1] Univ Bayreuth, Lehrstuhl Organ Chem 1, D-95440 Bayreuth, Germany
[2] Klinikum Bayreuth, Med Klin 2, D-95445 Bayreuth, Germany
[3] Klinikum Bayreuth, Geriatr Klin, D-95445 Bayreuth, Germany
关键词
lipid peroxidation; linoleic acid; LDL; atherosclerosis; 9-HODE; 13-HODE;
D O I
10.1016/S0009-3084(97)00095-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Linoleic acid is the most abundant fatty acid in human low density lipoproteins (LDL). Oxidation of LDL transforms linoleic acid to hydroperoxyderivatives. These are converted to 9-hydroxy-10,12-octadecadienoic acid (9-HODE) and 13-hydroxy-9,11-octadecadienoic acid (13-HODE). 9-HODE is much more abundant in oxidized LDL than other lipid peroxidation products and therefore an indicator of lipid peroxidation (LPO). In this study the 9-HODE content in the LDL of 19 obviously healthy volunteers and 17 atherosclerotic patients was investigated. The level of 9-HODE obtained from LDL of young atherosclerotic patients (aged 36-47 years) was increased by a factor of 20 when compared with samples from healthy volunteers of the same age group. The content of 9-HODE in the LDL of atherosclerotic patients aged between 69 and 94 years increased 30-100 fold when compared with young healthy individuals, but when compared with 'healthy' individuals of the same age group it was only 2-3 fold increased. Obviously, as individuals grow older LDL becomes more and more oxidized. Consequently, assuming that LDL oxidation is a precondition for atherosclerosis-older individuals will suffer from atherosclerosis, even if no easy detectable visible signs of this disease are recognizable. According to 9-HODE determination, the onset of the disease starts slowly in most individuals at around 50 years of age. (C) 1998 Elsevier Science Ireland Ltd.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 46 条
[1]   SERUM MALONDIALDEHYDE-LIKE MATERIAL (MDA-LM) IN ACUTE MYOCARDIAL-INFARCTION [J].
AZNAR, J ;
SANTOS, MT ;
VALLES, J ;
SALA, J .
JOURNAL OF CLINICAL PATHOLOGY, 1983, 36 (06) :712-715
[2]   THE OXYGENATION OF CHOLESTEROL ESTERS BY THE RETICULOCYTE LIPOXYGENASE [J].
BELKNER, J ;
WIESNER, R ;
KUHN, H ;
LANKIN, VZ .
FEBS LETTERS, 1991, 279 (01) :110-114
[3]   The role of oxidized lipoproteins in atherogenesis [J].
Berliner, JA ;
Heinecke, JW .
FREE RADICAL BIOLOGY AND MEDICINE, 1996, 20 (05) :707-727
[4]  
BLAKE DR, 1990, METABOLIC MOL BASIS, V20, P189
[5]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[6]   LIPIDS OF HUMAN ATHEROMA - ISOLATION OF HYDROXYOCTADECADIENOIC ACIDS FROM ADVANCED AORTAL LESIONS [J].
BROOKS, CJW ;
HARLAND, WA .
BIOCHIMICA ET BIOPHYSICA ACTA, 1970, 202 (03) :563-&
[7]   A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS [J].
BROWN, MS ;
GOLDSTEIN, JL .
SCIENCE, 1986, 232 (4746) :34-47
[8]   Lipid oxidation products in ischemic porcine heart tissue [J].
Dudda, A ;
Spiteller, G ;
Kobelt, F .
CHEMISTRY AND PHYSICS OF LIPIDS, 1996, 82 (01) :39-51
[9]   VITAMIN-E AND OTHER LIPOPHILIC ANTIOXIDANTS PROTECT LDL AGAINST OXIDATION [J].
ESTERBAUER, H ;
ROTHENEDER, M ;
STRIEGL, G ;
WAEG, G ;
ASHY, A ;
SATTLER, W ;
JURGENS, G .
FETT WISSENSCHAFT TECHNOLOGIE-FAT SCIENCE TECHNOLOGY, 1989, 91 (08) :316-324
[10]   THE ROLE OF LIPID-PEROXIDATION AND ANTIOXIDANTS IN OXIDATIVE MODIFICATION OF LDL [J].
ESTERBAUER, H ;
GEBICKI, J ;
PUHL, H ;
JURGENS, G .
FREE RADICAL BIOLOGY AND MEDICINE, 1992, 13 (04) :341-390